Literature DB >> 26818893

Willingness to initiate insulin among adults with type 2 diabetes in Australian primary care: Results from the Stepping Up Study.

Elizabeth Holmes-Truscott1, Irene Blackberry2, David N O'Neal3, John S Furler4, Jane Speight5.   

Abstract

AIMS: To determine 'hypothetical willingness' to initiate insulin, and identify associated factors, among adults with type 2 diabetes (T2DM) in primary care for whom insulin is clinically indicated.
METHODS: Eligible participants were adults with T2DM with an HbA1c ≥7.5% (58mmol/mol) and prescribed maximum oral hypoglycaemic agents. A total of 261 participants were recruited from 74 Victorian general practices: mean age 62±10 years; 39% (n=103) women; diabetes duration 10±6 years; HbA1c 9.0±1.3% (75±14mmol/mol). Data collected by the Stepping Up Study: demographic and clinical characteristics, 'willingness' to initiate insulin, insulin appraisals, depressive symptoms, and diabetes-related distress. A multinomial regression investigated predictors of 'willingness'.
RESULTS: Nineteen percent (n=50) were 'very willing' to initiate insulin, if recommended. The final regression model (R(2)=.44, χ(2)(12) 145.91, p<.001) demonstrated higher socioeconomic status and less negative attitudes to insulin were associated with increased willingness to initiate insulin.
CONCLUSIONS: Among adults with T2DM for whom insulin is clinically indicated, only one in five are 'very willing' to begin insulin therapy. Independent of demographics, clinical factors and emotional wellbeing, insulin appraisals were associated with 'willingness'. This study highlights the importance of addressing attitudinal barriers to insulin therapy among adults with T2DM in primary care to improve insulin receptiveness.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Insulin therapy; Primary care; Type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 26818893     DOI: 10.1016/j.diabres.2015.12.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

Review 1.  Assessing Psychological Insulin Resistance in Type 2 Diabetes: a Critical Comparison of Measures.

Authors:  E Holmes-Truscott; F Pouwer; J Speight
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

2.  A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy.

Authors:  Susan J Guzman
Journal:  Diabetes Spectr       Date:  2020-02

3.  Web-based intervention to reduce psychological barriers to insulin therapy among adults with non-insulin-treated type 2 diabetes: study protocol for a two-armed randomised controlled trial of 'Is insulin right for me?'.

Authors:  Elizabeth Holmes-Truscott; Edith E Holloway; Hanafi M Husin; John Furler; Virginia Hagger; Timothy C Skinner; Jane Speight
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 2.692

4.  GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice.

Authors:  John Furler; David Norman O'Neal; Jane Speight; Irene Blackberry; Jo-Anne Manski-Nankervis; Sharmala Thuraisingam; Katie de La Rue; Louise Ginnivan; Jessica Lea Browne; Elizabeth Holmes-Truscott; Kamlesh Khunti; Kim Dalziel; Jason Chiang; Ralph Audehm; Mark Kennedy; Malcolm Clark; Alicia Josephine Jenkins; Danny Liew; Philip Clarke; James Best
Journal:  BMJ Open       Date:  2018-07-17       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.